mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
-0.049 |
0.2 |
mRNA |
BEC |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.2 |
mRNA |
PLX4720 |
CTRPv2 |
pan-cancer |
AAC |
0.048 |
0.2 |
mRNA |
lapatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.05 |
0.2 |
mRNA |
KU-55933 |
CTRPv2 |
pan-cancer |
AAC |
-0.05 |
0.2 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.047 |
0.2 |
mRNA |
carboplatin:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.052 |
0.2 |
mRNA |
BRD-K51490254 |
CTRPv2 |
pan-cancer |
AAC |
0.052 |
0.2 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.044 |
0.2 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.046 |
0.2 |